Home > Boards > US Listed > Electronics and components > Ameri Holdings Inc. (AMRH)

AMERI Holdings Amalgamation Partner Jay Pharma Reports IRB

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Hawkeye_tt Member Profile
 
Followed By 15
Posts 4,629
Boards Moderated 1
Alias Born 06/27/03
160x600 placeholder
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/12/2021 6:04:38 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2021 4:06:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2021 4:08:13 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/6/2021 4:06:23 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/29/2021 4:06:07 PM
Securities Registration: Business Combination (s-4) Edgar (US Regulatory) - 6/22/2021 9:51:01 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/8/2021 2:26:36 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/27/2021 6:53:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/20/2021 4:06:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/17/2021 5:16:18 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/13/2021 12:18:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/12/2021 12:09:57 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 4/8/2021 6:10:05 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 4/2/2021 4:06:43 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2021 5:23:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2021 8:01:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/23/2021 4:05:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/11/2021 4:30:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/26/2021 4:21:57 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 2/24/2021 4:01:54 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 2/17/2021 10:14:04 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/12/2021 4:07:44 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/11/2021 3:58:28 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/10/2021 12:31:55 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 2/9/2021 9:17:16 AM
Hawkeye_tt   Tuesday, 06/02/20 10:32:21 AM
Re: None
Post # of 645 
AMERI Holdings Amalgamation Partner Jay Pharma Reports IRB Approval For Testing Proprietary CBD Formulation In Brain Cancer
June 02 2020 - 09:00AM
PR Newswire (US) Print
ATLANTA, June 2, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), today announced that its proposed amalgamation partner Jay Pharma Inc. ("Jay Pharma") received institutional review board ("IRB") approval by Rabin Medical Center in Petah Tikva, Israel for a Phase I/II clinical trial investigating Jay Pharma's proprietary cannabidiol ("CBD") formulation for the treatment of glioblastoma multiforme ("GBM"), a rare and aggressive form of brain cancer. This open-label, two-arm, randomized, prospective study is scheduled to commence following final approval from the Israel Ministry of Health, which is expected this summer.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences